USA: (+1) 929-659-6832
EU: (+44) 73-0721-4177
info@cognitivemarketresearch.com
D&B D-U-N-S No : 85-356-3074
Global Delirium Market Analysis 2026

Global Delirium

Global Delirium Market Analysis 2026

At cognitive, a dedicated team has worked on this report, we have disclosed one of the team member involved in the publication and client consultation process for your reference. You can initiate the discussion her via Book an appointment

Author By: Supriya Yadav

At cognitive, our research analyst works closely with Delirium market experts to validate the gathered data and have the expert's opinion available for our clients. You can book a consultation call with our research analyst and industry experts on board (Subject to time availability and paid consultation services)

Industry Expert: Not Disclosed (NDA)

The base year for the analysis is 2025. Historical data has been considered for the period from 2022 to 2025. The year 2026 is considered as the estimated base for forecasting, with projections covering the period from 2026 to 2034. When we deliver the report that time we updated report data till the purchase date.

Data Updated: March 2026

From the database of Cognitive, this is an unique identification number of reports and it will also have different reports associated with it.

Report ID: CMR821577

Report edition's total number of pages for pdf format (Approximate)

Report Pages: 250+

Rating and review received by the reader or subscriber of the said report.

Rating: 4.8 | Review: 6

Athenaeum Visualization Dashboard: Access your purchased data/Report/Service through a sophisticated, interactive interface. The Athenaeum Dashboard allows you to preview data/reports and store them in a customizable dashboard, enabling you to filter metrics and uncover deeper trends specific to your enterprise needs.
PDF Access: To ensure the highest level of data integrity and confidentiality, your premium report editions are delivered as password-protected PDF files. These are securely shared via email and remain accessible within your dedicated Athenaeum account for future reference.
Versatile Multi-Format Export (Excel & MS Word): We provide the flexibility to integrate our research directly into your internal workflows. Upon request, relevant quantitative data and qualitative insights from your purchased reports can be provided in fully editable Microsoft Excel and Word formats.
Multiple Cloud Accounts: Benefit from a dedicated, encrypted cloud account that ensures your market intelligence is available on-demand. Access your research from any device, at any time, and from any location. Multiple Accounts facilitating seamless collaboration across your collegue or whole organization.
Athenaeum AI Assistant(Value-Added Service): Elevate your research capabilities with Athenaeum AI Assistant, our proprietary 24/7 research assistant. Equivalent in depth to a dedicated research analyst, this AI-driven tool provides round-the-clock data support and instant insights to help you navigate complex market landscapes in real-time.

Format: Athenaeum Dashboard, Digital Link, PDF, EXCEL, MS Word, Cloud Access and Athenaeum AI Assistant

As Cognitive a market research and consulting firm, we can provide Delirium market Analysis and consultation services with the help of our data collection processes and Proprietary research methodology called Full Truth. We have in-house team of research analysts and network of industry experts on board. In fact, we provided high-impact consualtion services to the listed client in competitior analysis. As an extension of our bespoke consulting engagements, we also provide access to Proprietary datasets of market analysis publish, making authoritative industry intelligence accessible to the public domain.

8th Edition 2026 Revenue: USD Million/Billion Volume/Consumption: Unit

Delirium Market Analysis 2026

Proprietary Database, Market Surveys, Strategic Consultation & Advisory Services, Industry & Competitive Intelligence. along with Report Access and Athenaeum Dashboard Subscription — Revenue, Volume, Production, Trade Analysis, value chain and supply chain analysis, Market Size, Share, Forecast, Drivers, Trends, Growth Opportunities, ESG and more.

CAGR 2025–2033 ▲ 6.1%
Data Timeline Historical Data: 2022-2025 | Base Year: 2025 | Forecast Period: 2026-2034
Disease Type Segment Analysis Hyperactive delirium, Hypoactive delirium, Mixed delirium
End-Use Segment Analysis Hospitals, Speciality clinics
Distribution channel Segment Analysis Offline, Online
Route of administration Segment Analysis Oral, Parenteral, Others
Treatment Segment Analysis Medication, First-generation Antipsychotics, Second-generation Antipsychotics, Benzodiazepines, Others
Dosage Form Segment Analysis Tablets, Injections, Others
Regions & Countries Analysis
  • North America (United States, Canada, Mexico)
  • Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
  • South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
  • Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
  • Africa (East Africa, West Africa, North Africa, South Africa)
🔍 Explore Delirium Market Services: Bespoke Data | Athenaeum AI Dashboard | Market Surveys | Expert-Led Market Analysis | Market Size | Key Drivers | Emerging Trends | Restraints | 👉 Access Your Free Sample | Book Your Appointment

Share your contact details to receive free updated sample copy/pages of the recently published edition of Delirium Market Report 2025.

Global Delirium Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top 10 Countries Delirium Market Analysis includes Ranking, Market Size, Revenue in USD Million/Billion, Market Volume Unit

Loading...

Top 10 Countries Analysis of Delirium Market Share Distribution

Loading...

According to Cognitive Market Research, the global delirium market size is USD 0.248 billion in 2022 and will grow at a compound annual growth rate (CAGR) of 6.10% from 2023 to 2030.

Preview of Global Delirium Market Revenue

Delirium Market Size, CAGR and Industry Statistics
Market Size 2021 (A)2025 (A)2033 (P)CAGR
Global Delirium Market Sales Revenuexxxxxxxxxxxx6.1%
Note: A = Actual data, E = Estimated data, P = Projected data.

Delirium Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!

Delirium Market Report Description

Introduction of Delirium

Delirium is a neurological illness that causes abnormalities in a person's mental capacity. It produces mental perplexity as well as emotional upheaval. Delirium can be induced by a variety of circumstances, including old age, pharmaceutical exposure, alcohol misuse, surgery or other medical operations, and exposure to poisonous or infectious agents, physical trauma, food, and other behavioural and occupational variables. Several factors are driving the market, including the rising prevalence of delirium in ICU patients, the need for new diagnostic tools, and the acknowledgement of delirium as a major healthcare issue.

Within 24 hours after admission, the prevalence of delirium is reported to be 10%-31% among hospitalized patients.4 The frequency among older patients is reported to be 15%-53% after surgery5 6 and 80% among those admitted to the ICU.5 Previous research has linked delirium to longer hospital stays, institutionalization, and increased mortality in non-surgical and surgical patients in general wards, emergency departments, and intensive care units (ICUs).

(Source:www.ncbi.nlm.nih.gov/pmc/articles/PMC9476131/#:~:text=The%20prevalence%20of%20delirium%20is,within%2024%20hours%20of%20admission.)

Delirium Market Report

Delirium Market Size

Market driver of the Delirium Market

Key Driver for the Delirium Market

As the world's population ages, there is an increasing need for healthcare services, specialized care facilities, and pharmaceutical goods suited to the specific requirements of older persons. This demographic transition creates chances to expand healthcare infrastructure, such as hospitals, nursing homes, and home care services. Furthermore, the increased frequency of delirium, a prevalent illness among the aged that causes abrupt disorientation and cognitive impairment, needs the development of novel diagnostic techniques, therapeutic choices, and supportive care measures. 

According to the World Health Organization (WHO), the worldwide geriatric population, which was anticipated to be around 524 million in 2010, is likely to increase to over 2 billion by 2050.

(Source:www.who.int/news-room/fact-sheets/detail/ageing-and-health#:~:text=By%202050%2C%20the%20world's%20population,2050%20to%20reach%20426%20million.)

Market Dynamics of Delirium

  • The Lack of Non-Pharmacological Therapy Options Limits Market Growth

The primary method of treating delirium is to utilize drugs such as antipsychotics and sedatives. These pharmaceutical therapies, however, may have limits and significant negative effects. Non-pharmacological treatments, on the other hand, focus on environmental changes, cognitive stimulation, and supportive interventions to provide alternate and complementary ways to controlling delirium. Unfortunately, non-pharmacological options for delirium therapy are scarce and difficult to apply. This is due to a variety of causes, including a lack of defined practices, a lack of awareness among healthcare personnel, and resource limits in healthcare settings.

Impact of COVID-19 on the Delirium Market

The pandemic has created significant obstacles in controlling and treating delirium, particularly in hospital settings such as intensive care units (ICUs). The growing demand on healthcare systems, limited resources and the necessity to prioritize COVID-19 patients have all had an impact on delirium patients' overall treatment and attention. Furthermore, infection control techniques such as restricted visiting policies and isolation protocols have reduced social interaction and cognitive stimulation for patients, potentially worsening delirium symptoms.

We have various report editions of Delirium Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Impact of Tariff Trumph on Pharmaceuticals Industry

The April 2025 “Liberation Day Tariffs” (10–46%) have disrupted global pharmaceutical trade, raising costs for APIs, packaging, and machinery from China and India. Generic drug makers, biopharma, vaccines, and CMOs face higher expenses, supply chain delays, and regulatory hurdles, while EU retaliation has further strained U.S. exports. Clinical trials are also delayed due to tariffs on drugs and kits. In this landscape, market research is vital, providing real-time data on pricing, suppliers, and tariff impacts to help companies optimize supply chains, find alternative hubs, and maintain competitiveness.

Competitive Landscape of Delirium Market

Leading market players are extensively spending in R&D to extend their product ranges, which will help the delirium market grow even further. Important market developments include new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other firms. To grow and thrive in a more competitive and increasing market setting, the delirium sector must provide cost-effective products.

 December, 2020, The FDA granted Aurobindo Pharma final approval to manufacture and commercialize Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, 200 g/50 mL and 400 g/100 mL Single Dose flexible containers (Bags).

(Source:www.business-standard.com/article/news-cm/aurobindo-receives-usfda-approval-for-dexmedetomidine-hydrochloride-in-0-9-sodium-chloride-injection-120120900218_1.html)

September 2020, Dr. Reddy's Laboratories launched Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection form for sedation of first intubated and mechanically ventilated patients in an intensive care setting for the treatment of hyperactive delirium (agitation in delirium).

(Source:www.expresspharma.in/dr-reddys-launches-dexmedetomidine-hydrochloride-in-0-9-sodium-chloride-injection-in-us/)

June 2021, The FDA has approved ALKERMES plc's LYBALVITM (olanzapine and samidorphan) for the acute treatment of mixed episodes, either as a monotherapy or as an addition to lithium or valproate.

(Source:investor.alkermes.com/news-releases/news-release-details/alkermes-announces-fda-approval-lybalvitm-treatment)

Top Companies Market Share in Delirium Industry: (In no particular order of Rank)

Companies 2022 (A)2023 (A)2024 (A)2025 (A)
Dr Franz Kohler Chemie GmbHxxxxxxxxxxxxxxxx
Gala BioPharma Ltd.xxxxxxxxxxxxxxxx
Teva pharmaceuticalsxxxxxxxxxxxxxxxx
Mylan N.V.xxxxxxxxxxxxxxxx
Pfizer Inc.xxxxxxxxxxxxxxxx
Regenstrief Institute Incxxxxxxxxxxxxxxxx
Novartis AGxxxxxxxxxxxxxxxx
Otsuka Pharmaceutical Co. Ltd.xxxxxxxxxxxxxxxx
Bristol-Myers Squibbxxxxxxxxxxxxxxxx
Fraser Healthxxxxxxxxxxxxxxxx
Zydus Cadilaxxxxxxxxxxxxxxxx
Note: A = Actual data, E = Estimated data, P = Projected data.

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

The North America Delirium Market Dominate the Largest Share of Global Market

According to Cognitive Market Research, due to the localisation of novel therapeutic options, the North American delirium market will dominate this industry. Rising rates of suicide thoughts and mental health diseases in the region are fueling the region's increasing embrace of different innovations in mental health treatment choices. Better delirium treatment options are also in high demand as the general public's knowledge of mental health concerns grows in the aftermath of the COVID-19 epidemic. According to Cognitive Market Research, the United States has always been a leading player in the North American delirium market. Its excellent healthcare infrastructure, research skills, and emphasis on innovation all contribute to its industry supremacy.

Furthermore, because of an increase in the number of older individuals in numerous countries, including China and India, the Asia-Pacific Delirium Market is predicted to develop at the quickest CAGR from 2023 to 2032. The presence of generic manufacturers and the expansion of healthcare facilities in the area are expected to contribute to the market's revenue growth over the forecast period.

The current report Scope analyzes Delirium Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

  • North America (United States, Canada, Mexico)
  • Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
  • South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
  • Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
  • Africa (East Africa, West Africa, North Africa, South Africa)

Delirium Market Share (%) by Region (2022-2034)

The above graph is for illustrative purposes only.

To learn more about geographical trends request the free sample pages.

Get Free Sample

Author's Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Global Delirium Market is witnessing significant growth in the near future.

In 2023, the Hyperactive delirium segment accounted for noticeable share of global Delirium Market and is projected to experience significant growth in the near future.

The Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.

Some of the key companies Dr Franz Kohler Chemie GmbH , Teva pharmaceuticals and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.

Author's Detail

Supriya Yadav

Research Analyst

LinkedIn | Profile | Book Appointment

Supriya Yadav is a dedicated market research professional with expertise in the aerospace and defence industry. At Cognitive Market Research, she focuses on delivering strategic insights into aviation advancements, defence technologies, and global security trends shaping the future of the sector.

Her research covers areas such as military modernization, commercial aviation growth, space exploration, and defence procurement strategies. With a strong analytical mindset and attention to technological evolution, Supriya provides data-driven intelligence that supports innovation, strategic planning, and informed decision-making within the aerospace and defence domain.

Bio :

As a Research Analyst, I bring over two years of experience in market research, data analysis, and market estimation. I specialize in turning complex datasets into meaningful insights that help businesses identify opportunities, understand market dynamics, and make confident, growth-focused decisions.

My expertise spans across analyzing industry trends, forecasting market potential, mapping competitive landscapes, and studying consumer behavior to deliver actionable recommendations. With an MBA in Marketing and Finance, I combine strong analytical skills with strategic thinking, ensuring that every project I work on contributes real value to clients.

I am passionate about using research to uncover patterns, anticipate shifts, and deliver insights that drive measurable business impact. My goal is to continuously learn, innovate, and provide data-driven solutions that empower clients to succeed in a competitive environment.

Read More

Frequently Asked Questions (FAQs)

What is the size of the delirium industry market in 2022?
The delirium industry has a global market value of $0.248 billion in 2022.
What is the anticipated growth rate for the market for delirium over the upcoming years?
The global market is expected to grow at a CAGR of 6.10% during the projection period.
In which region is the delirium market the largest?
The region with the largest revenue share in the global market for delirium in 2022 was North America.
In the foreseeable future, which region is predicted to expand the fastest?
Over the coming years, Asia Pacific will see the fastest growth in the market for delirium.
In 2022, which country will command the delirium industry in North America?
In terms of revenue, the United States dominated the market for delirium in North America in 2022.
What primary variables are affecting the delirium market?
The main reasons influencing the growth of the delirium industry include geriatric population growth and rising prevalence of delirium in ICU patients.
What segment of the delirium market is the largest?
The Offline market has the largest global share, broken down by component.
Which service category dominates the market for delirium?
In 2022, the hospitals market held a sizeable market share in terms of service revenue.

Reviews

No reviews yet. Be the first to review!

Delirium Market Segmentation Analysis from 2022 till 2034

Global Delirium Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Delirium Industry growth. Delirium market has been segmented with the help of its Disease Type, End-Use Distribution channel, and others. Delirium market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

Disease Type Segment Analysis

According to Cognitive Market Research, the hyperactive delirium market category is in high demand. A variant of delirium known as hyperactive delirium is distinguished by agitation, restlessness, and increased motor activity. It is frequently more obvious and can present difficulties in managing and treating delirium. The need for hyperactive delirium therapies and therapeutic techniques is increasing as healthcare practitioners attempt to effectively manage the symptoms and improve patient outcomes. 

The hypoactive delirium segment is an important part of the Delirium Market. The symptoms of hypoactive delirium include decreased motor activity, lethargy, and slower cognitive functions. Because of its modest symptoms, it is frequently misdiagnosed and missed.

  • Hyperactive delirium
  • Hypoactive delirium
  • Mixed delirium

Delirium Market Share (%) by Disease Type in 2022-2034

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Delirium Industry. Request a Free Sample PDF!

End-Use Segment Analysis

The hospitals category brought in the greatest money. Hospitals play an important role in delirium diagnosis, administration, and management. Medical personnel such as physicians, nurses, and specialists evaluate patients, offer medical therapies, and monitor the progression of delirium episodes in various settings.

According to Cognitive Market Research, the specialty clinic segment is rapidly expanding. These clinics offer specialized care and interventions for delirium patients, as well as individualized treatment regimens and expert support. The growing acknowledgment of delirium as a major healthcare concern has increased demand for these specialty clinics, resulting in their extraordinary expansion.

  • Hospitals
  • Speciality clinics

Delirium Market Share (%) by End-Use in 2022-2034

2022

2026

2034

The above Graph is for representation purposes only. This chart does not depict actual Market share.

To learn more about market share request the free sample pages.

Get Free Sample

Distribution channel Segmentation Analysis from 2022 till 2034: Offline, Online

According to Cognitive Market Research, the Offline segment has the largest market share in the delirium market since it refers to non-digital or physical interventions and treatments for delirium management. This encompasses non-pharmacological therapy, environmental changes, and supportive care delivered in healthcare settings.

The online segment is a key part of the delirious market. It includes digital actions and tools that can help with delirium management and treatment. Online instructional resources, telemedicine consultations, virtual cognitive stimulation programs, and remote monitoring systems are examples of this.

  • Offline
  • Online

Route of administration Segmentation Analysis from 2022 till 2034: Oral, Parenteral, Others

The parenteral sector accounts for the majority of market share. Parenteral drugs are those that are supplied via methods other than the digestive tract, such as intravenous injections or infusions. These methods allow for rapid and direct medicine delivery, making them extremely helpful in treating delirium symptoms. Because of its capacity to deliver instant relief and exact dosing, the parenteral portion is preferred.

The oral segment is a significant part of the Market. Oral medicines are delivered and ingested through the mouth, making them a practical and extensively utilized technique of delirium management. They are simple to give and, in some situations, can be self-administered by patients.

  • Oral
  • Parenteral
  • Others

Treatment Segmentation Analysis from 2022 till 2034: Medication, First-generation Antipsychotics, Second-generation Antipsychotics, Benzodiazepines, Others

According to Cognitive Market Research, the market was dominated by second-generation antipsychotics. Because these drugs have a lower affinity for dopamine receptors, their side effects will be decreased. This is why the market need for delirium management is expanding.

The first-generation antipsychotics sector is also a big market participant. For the treatment of delirium symptoms, first-generation antipsychotics, also known as conventional antipsychotics, have been widely employed. They act by inhibiting dopamine receptors in the brain, which helps to relieve delirium-related psychosis and agitation.

  • Medication
  • First-generation Antipsychotics
  • Second-generation Antipsychotics
  • Benzodiazepines
  • Others

Dosage Form Segmentation Analysis from 2022 till 2034: Tablets, Injections, Others

Tablets are the most popular form in the market. Tablets are a popular alternative for addressing a variety of disorders, including delirium, since they provide convenience, ease of administration, and a wide range of dose options. They are simply taken orally and are frequently self-administered by patients, providing for greater independence and therapeutic flexibility.

Injections are another popular method of dose on the market. Injections carry medication directly and quickly into the body, making them extremely helpful in the treatment of delirium and other medical problems. They are often given by healthcare experts and ensure proper dosing.

  • Tablets
  • Injections
  • Others

Delirium Market Report Table of Content

Disclaimer:

  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Disease Type Hyperactive delirium, Hypoactive delirium, Mixed delirium
End-Use Hospitals, Speciality clinics
Distribution channel Offline, Online
Route of administration Oral, Parenteral, Others
Treatment Medication, First-generation Antipsychotics, Second-generation Antipsychotics, Benzodiazepines, Others
Dosage Form Tablets, Injections, Others
List of Competitors Dr Franz Kohler Chemie GmbH, Gala BioPharma Ltd., Teva pharmaceuticals, Mylan N.V., Pfizer Inc., Regenstrief Institute Inc, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Bristol-Myers Squibb, Fraser Health, Zydus Cadila
Expand All

Chapter 1 2026 Geopolitical Outlook - Delirium Market Detailed Analysis
  • 1.1 Global Power Realignment & Strategic Alliances
  • 1.2 Geopolitical Risk Landscape & Conflict Hotspots
  • 1.3 International Trade Relations & Market Access Environment
  • 1.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
  • 1.5 Supply Chain Resilience, Localization & Resource Nationalism
  • 1.6 Technology Sovereignty & Digital Geopolitics
  • 1.7 Strategic Implications for Investment, Growth & Market Entry
  • 2.1 Competitive Landscape Disruption & Strategic Shifts
  • 2.2 AI-Driven Transformation of Industry Value Chain
  • 2.3 Evolution of Business Models & Revenue Streams
  • 2.4 Operational Efficiency & Cost Structure Transformation
  • 2.5 Product, Service & Innovation Acceleration
  • 2.6 Customer Behavior & Demand Evolution
  • 2.7 Future Outlook: AI-Led Market Evolution & Strategic Implications
  • 3.1 Global Delirium Revenue Market Size, Trend Analysis 2022 - 2034
  • 3.2 Global Delirium Volume Market Sales, Trend Analysis 2022 - 2034

  • Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

    3.3 Global Delirium Market Size By Regions 2022 - 2034
    • 3.3.1 Global Delirium Revenue Market Size By Region
    • 3.3.2 Global Delirium Volume Market Sales By Region
  • 3.4 Global Delirium Market Size By Disease Type 2022 - 2034
    • 3.4.1 Hyperactive delirium Market Size
    • 3.4.2 Hypoactive delirium Market Size
    • 3.4.3 Mixed delirium Market Size
  • 3.5 Global Delirium Volume Market Sales By Disease Type 2022 - 2034
    • 3.5.1 Hyperactive delirium Sales Volume
    • 3.5.2 Hypoactive delirium Sales Volume
    • 3.5.3 Mixed delirium Sales Volume
  • 3.6 Global Delirium Market Size By End-Use 2022 - 2034
    • 3.6.1 Hospitals Market Size
    • 3.6.2 Speciality clinics Market Size
  • 3.7 Global Delirium Volume Market Sales By End-Use 2022 - 2034
    • 3.7.1 Hospitals Sales Volume
    • 3.7.2 Speciality clinics Sales Volume
  • 3.8 Global Delirium Market Size By Distribution channel 2022 - 2034
    • 3.8.1 Offline Market Size
    • 3.8.2 Online Market Size
  • 3.9 Global Delirium Volume Market Sales By Distribution channel 2022 - 2034
    • 3.9.1 Offline Sales Volume
    • 3.9.2 Online Sales Volume
  • 3.10 Global Delirium Market Size By Route of administration for 2022 - 2034
    • 3.10.1 Oral Market Size
    • 3.10.2 Parenteral Market Size
    • 3.10.3 Others Market Size
  • 3.11 Global Delirium Volume Market Sales By Route of administration 2022 - 2034
    • 3.11.1 Oral Sales Volume
    • 3.11.2 Parenteral Sales Volume
    • 3.11.3 Others Sales Volume
  • 3.12 Global Delirium Market Size By Treatment for 2022 - 2034
    • 3.12.1 Medication Market Size
    • 3.12.2 First-generation Antipsychotics Market Size
    • 3.12.3 Second-generation Antipsychotics Market Size
    • 3.12.4 Benzodiazepines Market Size
    • 3.12.5 Others Market Size
  • 3.13 Global Delirium Volume Market Sales By Treatment 2022 - 2034
    • 3.13.1 Medication Sales Volume
    • 3.13.2 First-generation Antipsychotics Sales Volume
    • 3.13.3 Second-generation Antipsychotics Sales Volume
    • 3.13.4 Benzodiazepines Sales Volume
    • 3.13.5 Others Sales Volume
  • 3.14 Global Delirium Market Size By Dosage Form for 2022 - 2034
    • 3.14.1 Tablets Market Size
    • 3.14.2 Injections Market Size
    • 3.14.3 Others Market Size
    • 3.14.1 Tablets Market Size
    • 3.14.2 Injections Market Size
    • 3.14.3 Others Market Size
  • 3.15 Global Delirium Volume Market Sales By Dosage Form 2022 - 2034
    • 3.15.1 Tablets Sales Volume
    • 3.15.2 Injections Sales Volume
    • 3.15.3 Others Sales Volume
  • 3.16 Global Level Competitor Analysis (Subject to Data Availability (Private Players))

  • You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)

    3.17 Executive Summary Global Market (2021 vs 2025 vs 2033)
    • 3.17.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
    • 3.17.2 Regional Volume Market Summary 2021 vs 2025 vs 2033
    • 3.17.3 Global Market Revenue Split By Disease Type
    • 3.17.4 Global Volume Market Split By Disease Type
    • 3.17.5 Global Market Revenue Split By End-Use
    • 3.17.6 Global Volume Market Split By End-Use
    • 3.17.7 Global Market Revenue Split By Distribution channel
    • 3.17.8 Global Volume Market Split By Distribution channel
    • 3.17.9 Global Market Revenue Split By Route of administration
    • 3.17.10 Global Volume Market Split By Route of administration
    • 3.17.11 Global Market Revenue Split By Treatment
    • 3.17.12 Global Volume Market Split By Treatment
    • 3.17.13 Global Volume Market Split By Dosage Form

    • Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable

      3.17.14 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
  • 4.1 North America Delirium Market Outlook
    • 4.1.1 North America Delirium Market Size 2022 - 2034
    • 4.1.2 North America Delirium Volume Market Sales 2022 - 2034
    • 4.1.3 North America Delirium Market Size By Country 2022 - 2034
    • 4.1.4 North America Delirium Volume Market Sales By Country 2022 - 2034
    • 4.1.5 North America Delirium Market Size by Disease Type 2022 - 2034
      • 4.1.5.1 North America Hyperactive delirium Market Size
      • 4.1.5.2 North America Hypoactive delirium Market Size
      • 4.1.5.3 North America Mixed delirium Market Size
    • 4.1.6 North America Delirium Volume Market Sales by Disease Type 2022 - 2034
      • 4.1.6.1 North America Hyperactive delirium Sales Volume
      • 4.1.6.2 North America Hypoactive delirium Sales Volume
      • 4.1.6.3 North America Mixed delirium Sales Volume
    • 4.1.7 North America Delirium Market Size by End-Use 2022 - 2034
      • 4.1.7.1 North America Hospitals Market Size
      • 4.1.7.2 North America Speciality clinics Market Size
    • 4.1.8 North America Delirium Volume Market Sales by End-Use 2022 - 2034
      • 4.1.8.1 North America Hospitals Sales Volume
      • 4.1.8.2 North America Speciality clinics Sales Volume
    • 4.1.9 North America Delirium Market Size by Distribution channel 2022 - 2034
      • 4.1.9.1 North America Offline Market Size
      • 4.1.9.2 North America Online Market Size
    • 4.1.10 North America Delirium Volume Market Sales by Distribution channel 2022 - 2034
      • 4.1.10.1 North America Offline Sales Volume
      • 4.1.10.2 North America Online Sales Volume
    • 4.1.11 North America Delirium Market Size by Route of administration 2022 - 2034
      • 4.1.11.1 North America Oral Market Size
      • 4.1.11.2 North America Parenteral Market Size
      • 4.1.11.3 North America Others Market Size
    • 4.1.12 North America Delirium Volume Market Sales by Route of administration 2022 - 2034
      • 4.1.12.1 North America Oral Sales Volume
      • 4.1.12.2 North America Parenteral Sales Volume
      • 4.1.12.3 North America Others Sales Volume
    • 4.1.13 North America Delirium Market Size by Treatment 2022 - 2034
      • 4.1.13.1 North America Medication Market Size
      • 4.1.13.2 North America First-generation Antipsychotics Market Size
      • 4.1.13.3 North America Second-generation Antipsychotics Market Size
      • 4.1.13.4 North America Benzodiazepines Market Size
      • 4.1.13.5 North America Others Market Size
    • 4.1.14 North America Delirium Volume Market Sales by Treatment 2022 - 2034
      • 4.1.14.1 North America Medication Sales Volume
      • 4.1.14.2 North America First-generation Antipsychotics Sales Volume
      • 4.1.14.3 North America Second-generation Antipsychotics Sales Volume
      • 4.1.14.4 North America Benzodiazepines Sales Volume
      • 4.1.14.5 North America Others Sales Volume
    • 4.1.15 North America Delirium Market Size by Dosage Form 2022 - 2034
      • 4.1.15.1 North America Tablets Market Size
      • 4.1.15.2 North America Injections Market Size
      • 4.1.15.3 North America Others Market Size
    • 4.1.16 North America Delirium Volume Market Sales by Dosage Form 2022 - 2034
      • 4.1.16.1 North America Tablets Sales Volume
      • 4.1.16.2 North America Injections Sales Volume
      • 4.1.16.3 North America Others Sales Volume
  • 5.1 Europe Delirium Market Outlook
    • 5.1.1 Europe Delirium Market Size 2022 - 2034
    • 5.1.2 Europe Delirium Volume Market Sales 2022 - 2034
    • 5.1.3 Europe Delirium Market Size By Country 2022 - 2034
    • 5.1.4 Europe Delirium Volume Market Sales By Country 2022 - 2034
    • 5.1.5 Europe Delirium Market Size by Disease Type 2022 - 2034
      • 5.1.5.1 Europe Hyperactive delirium Market Size
      • 5.1.5.2 Europe Hypoactive delirium Market Size
      • 5.1.5.3 Europe Mixed delirium Market Size
    • 5.1.6 Europe Delirium Volume Market Sales by Disease Type 2022 - 2034
      • 5.1.6.1 Europe Hyperactive delirium Sales Volume
      • 5.1.6.2 Europe Hypoactive delirium Sales Volume
      • 5.1.6.3 Europe Mixed delirium Sales Volume
    • 5.1.7 Europe Delirium Market Size by End-Use 2022 - 2034
      • 5.1.7.1 Europe Hospitals Market Size
      • 5.1.7.2 Europe Speciality clinics Market Size
    • 5.1.8 Europe Delirium Volume Market Sales by End-Use 2022 - 2034
      • 5.1.8.1 Europe Hospitals Sales Volume
      • 5.1.8.2 Europe Speciality clinics Sales Volume
    • 5.1.9 Europe Delirium Market Size by Distribution channel 2022 - 2034
      • 5.1.9.1 Europe Offline Market Size
      • 5.1.9.2 Europe Online Market Size
    • 5.1.10 Europe Delirium Volume Market Sales by Distribution channel 2022 - 2034
      • 5.1.10.1 Europe Offline Sales Volume
      • 5.1.10.2 Europe Online Sales Volume
    • 5.1.11 Europe Delirium Market Size by Route of administration 2022 - 2034
      • 5.1.11.1 Europe Oral Market Size
      • 5.1.11.2 Europe Parenteral Market Size
      • 5.1.11.3 Europe Others Market Size
    • 5.1.12 Europe Delirium Volume Market Sales by Route of administration 2022 - 2034
      • 5.1.12.1 Europe Oral Sales Volume
      • 5.1.12.2 Europe Parenteral Sales Volume
      • 5.1.12.3 Europe Others Sales Volume
    • 5.1.13 Europe Delirium Market Size by Treatment 2022 - 2034
      • 5.1.13.1 Europe Medication Market Size
      • 5.1.13.2 Europe First-generation Antipsychotics Market Size
      • 5.1.13.3 Europe Second-generation Antipsychotics Market Size
      • 5.1.13.4 Europe Benzodiazepines Market Size
      • 5.1.13.5 Europe Others Market Size
    • 5.1.14 Europe Delirium Volume Market Sales by Treatment 2022 - 2034
      • 5.1.14.1 Europe Medication Sales Volume
      • 5.1.14.2 Europe First-generation Antipsychotics Sales Volume
      • 5.1.14.3 Europe Second-generation Antipsychotics Sales Volume
      • 5.1.14.4 Europe Benzodiazepines Sales Volume
      • 5.1.14.5 Europe Others Sales Volume
    • 5.1.15 Europe Delirium Market Size by Dosage Form 2022 - 2034
      • 5.1.15.1 Europe Tablets Market Size
      • 5.1.15.2 Europe Injections Market Size
      • 5.1.15.3 Europe Others Market Size
    • 5.1.16 Europe Delirium Volume Market Sales by Dosage Form 2022 - 2034
      • 5.1.16.1 Europe Tablets Sales Volume
      • 5.1.16.2 Europe Injections Sales Volume
      • 5.1.16.3 Europe Others Sales Volume
  • 6.1 Asia Pacific Delirium Market Outlook
    • 6.1.1 Asia Pacific Delirium Market Size 2022 - 2034
    • 6.1.2 Asia Pacific Delirium Volume Market Sales 2022 - 2034
    • 6.1.3 Asia Pacific Delirium Market Size By Country 2022 - 2034
    • 6.1.4 Asia Pacific Delirium Volume Market Sales By Country 2022 - 2034
    • 6.1.5 Asia Pacific Delirium Market Size by Disease Type 2022 - 2034
      • 6.1.5.1 Asia Pacific Hyperactive delirium Market Size
      • 6.1.5.2 Asia Pacific Hypoactive delirium Market Size
      • 6.1.5.3 Asia Pacific Mixed delirium Market Size
    • 6.1.6 Asia Pacific Delirium Volume Market Sales by Disease Type 2022 - 2034
      • 6.1.6.1 Asia Pacific Hyperactive delirium Sales Volume
      • 6.1.6.2 Asia Pacific Hypoactive delirium Sales Volume
      • 6.1.6.3 Asia Pacific Mixed delirium Sales Volume
    • 6.1.7 Asia Pacific Delirium Market Size by End-Use 2022 - 2034
      • 6.1.7.1 Asia Pacific Hospitals Market Size
      • 6.1.7.2 Asia Pacific Speciality clinics Market Size
    • 6.1.8 Asia Pacific Delirium Volume Market Sales by End-Use 2022 - 2034
      • 6.1.8.1 Asia Pacific Hospitals Sales Volume
      • 6.1.8.2 Asia Pacific Speciality clinics Sales Volume
    • 6.1.9 Asia Pacific Delirium Market Size by Distribution channel 2022 - 2034
      • 6.1.9.1 Asia Pacific Offline Market Size
      • 6.1.9.2 Asia Pacific Online Market Size
    • 6.1.10 Asia Pacific Delirium Volume Market Sales by Distribution channel 2022 - 2034
      • 6.1.10.1 Asia Pacific Offline Sales Volume
      • 6.1.10.2 Asia Pacific Online Sales Volume
    • 6.1.11 Asia Pacific Delirium Market Size by Route of administration 2022 - 2034
      • 6.1.11.1 Asia Pacific Oral Market Size
      • 6.1.11.2 Asia Pacific Parenteral Market Size
      • 6.1.11.3 Asia Pacific Others Market Size
    • 6.1.12 Asia Pacific Delirium Volume Market Sales by Route of administration 2022 - 2034
      • 6.1.12.1 Asia Pacific Oral Sales Volume
      • 6.1.12.2 Asia Pacific Parenteral Sales Volume
      • 6.1.12.3 Asia Pacific Others Sales Volume
    • 6.1.13 Asia Pacific Delirium Market Size by Treatment 2022 - 2034
      • 6.1.13.1 Asia Pacific Medication Market Size
      • 6.1.13.2 Asia Pacific First-generation Antipsychotics Market Size
      • 6.1.13.3 Asia Pacific Second-generation Antipsychotics Market Size
      • 6.1.13.4 Asia Pacific Benzodiazepines Market Size
      • 6.1.13.5 Asia Pacific Others Market Size
    • 6.1.14 Asia Pacific Delirium Volume Market Sales by Treatment 2022 - 2034
      • 6.1.14.1 Asia Pacific Medication Sales Volume
      • 6.1.14.2 Asia Pacific First-generation Antipsychotics Sales Volume
      • 6.1.14.3 Asia Pacific Second-generation Antipsychotics Sales Volume
      • 6.1.14.4 Asia Pacific Benzodiazepines Sales Volume
      • 6.1.14.5 Asia Pacific Others Sales Volume
    • 6.1.15 Asia Pacific Delirium Market Size by Dosage Form 2022 - 2034
      • 6.1.15.1 Asia Pacific Tablets Market Size
      • 6.1.15.2 Asia Pacific Injections Market Size
      • 6.1.15.3 Asia Pacific Others Market Size
    • 6.1.16 Asia Pacific Delirium Volume Market Sales by Dosage Form 2022 - 2034
      • 6.1.16.1 Asia Pacific Tablets Sales Volume
      • 6.1.16.2 Asia Pacific Injections Sales Volume
      • 6.1.16.3 Asia Pacific Others Sales Volume
  • 7.1 South America Delirium Market Outlook
    • 7.1.1 South America Delirium Market Size 2022 - 2034
    • 7.1.2 South America Delirium Volume Market Sales 2022 - 2034
    • 7.1.3 South America Delirium Market Size By Country 2022 - 2034
    • 7.1.4 South America Delirium Volume Market Sales By Country 2022 - 2034
    • 7.1.5 South America Delirium Market Size by Disease Type 2022 - 2034
      • 7.1.5.1 South America Hyperactive delirium Market Size
      • 7.1.5.2 South America Hypoactive delirium Market Size
      • 7.1.5.3 South America Mixed delirium Market Size
    • 7.1.6 South America Delirium Volume Market Sales by Disease Type 2022 - 2034
      • 7.1.6.1 South America Hyperactive delirium Sales Volume
      • 7.1.6.2 South America Hypoactive delirium Sales Volume
      • 7.1.6.3 South America Mixed delirium Sales Volume
    • 7.1.7 South America Delirium Market Size by End-Use 2022 - 2034
      • 7.1.7.1 South America Hospitals Market Size
      • 7.1.7.2 South America Speciality clinics Market Size
    • 7.1.8 South America Delirium Volume Market Sales by End-Use 2022 - 2034
      • 7.1.8.1 South America Hospitals Sales Volume
      • 7.1.8.2 South America Speciality clinics Sales Volume
    • 7.1.9 South America Delirium Market Size by Distribution channel 2022 - 2034
      • 7.1.9.1 South America Offline Market Size
      • 7.1.9.2 South America Online Market Size
    • 7.1.10 South America Delirium Volume Market Sales by Distribution channel 2022 - 2034
      • 7.1.10.1 South America Offline Sales Volume
      • 7.1.10.2 South America Online Sales Volume
    • 7.1.11 South America Delirium Market Size by Route of administration 2022 - 2034
      • 7.1.11.1 South America Oral Market Size
      • 7.1.11.2 South America Parenteral Market Size
      • 7.1.11.3 South America Others Market Size
    • 7.1.12 South America Delirium Volume Market Sales by Route of administration 2022 - 2034
      • 7.1.12.1 South America Oral Sales Volume
      • 7.1.12.2 South America Parenteral Sales Volume
      • 7.1.12.3 South America Others Sales Volume
    • 7.1.13 South America Delirium Market Size by Treatment 2022 - 2034
      • 7.1.13.1 South America Medication Market Size
      • 7.1.13.2 South America First-generation Antipsychotics Market Size
      • 7.1.13.3 South America Second-generation Antipsychotics Market Size
      • 7.1.13.4 South America Benzodiazepines Market Size
      • 7.1.13.5 South America Others Market Size
    • 7.1.14 South America Delirium Volume Market Sales by Treatment 2022 - 2034
      • 7.1.14.1 South America Medication Sales Volume
      • 7.1.14.2 South America First-generation Antipsychotics Sales Volume
      • 7.1.14.3 South America Second-generation Antipsychotics Sales Volume
      • 7.1.14.4 South America Benzodiazepines Sales Volume
      • 7.1.14.5 South America Others Sales Volume
    • 7.1.15 South America Delirium Market Size by Dosage Form 2022 - 2034
      • 7.1.15.1 South America Tablets Market Size
      • 7.1.15.2 South America Injections Market Size
      • 7.1.15.3 South America Others Market Size
    • 7.1.16 South America Delirium Volume Market Sales by Dosage Form 2022 - 2034
      • 7.1.16.1 South America Tablets Sales Volume
      • 7.1.16.2 South America Injections Sales Volume
      • 7.1.16.3 South America Others Sales Volume
  • 8.1 Middle East Delirium Market Outlook
    • 8.1.1 Middle East Delirium Market Size 2022 - 2034
    • 8.1.2 Middle East Delirium Volume Market Sales 2022 - 2034
    • 8.1.3 Middle East Delirium Market Size By Country 2022 - 2034
    • 8.1.4 Middle East Delirium Volume Market Sales By Country 2022 - 2034
    • 8.1.5 Middle East Delirium Market Size by Disease Type 2022 - 2034
      • 8.1.5.1 Middle East Hyperactive delirium Market Size
      • 8.1.5.2 Middle East Hypoactive delirium Market Size
      • 8.1.5.3 Middle East Mixed delirium Market Size
    • 8.1.6 Middle East Delirium Volume Market Sales by Disease Type 2022 - 2034
      • 8.1.6.1 Middle East Hyperactive delirium Sales Volume
      • 8.1.6.2 Middle East Hypoactive delirium Sales Volume
      • 8.1.6.3 Middle East Mixed delirium Sales Volume
    • 8.1.7 Middle East Delirium Market Size by End-Use 2022 - 2034
      • 8.1.7.1 Middle East Hospitals Market Size
      • 8.1.7.2 Middle East Speciality clinics Market Size
    • 8.1.8 Middle East Delirium Volume Market Sales by End-Use 2022 - 2034
      • 8.1.8.1 Middle East Hospitals Sales Volume
      • 8.1.8.2 Middle East Speciality clinics Sales Volume
    • 8.1.9 Middle East Delirium Market Size by Distribution channel 2022 - 2034
      • 8.1.9.1 Middle East Offline Market Size
      • 8.1.9.2 Middle East Online Market Size
    • 8.1.10 Middle East Delirium Volume Market Sales by Distribution channel 2022 - 2034
      • 8.1.10.1 Middle East Offline Sales Volume
      • 8.1.10.2 Middle East Online Sales Volume
    • 8.1.11 Middle East Delirium Market Size by Route of administration 2022 - 2034
      • 8.1.11.1 Middle East Oral Market Size
      • 8.1.11.2 Middle East Parenteral Market Size
      • 8.1.11.3 Middle East Others Market Size
    • 8.1.12 Middle East Delirium Volume Market Sales by Route of administration 2022 - 2034
      • 8.1.12.1 Middle East Oral Sales Volume
      • 8.1.12.2 Middle East Parenteral Sales Volume
      • 8.1.12.3 Middle East Others Sales Volume
    • 8.1.13 Middle East Delirium Market Size by Treatment 2022 - 2034
      • 8.1.13.1 Middle East Medication Market Size
      • 8.1.13.2 Middle East First-generation Antipsychotics Market Size
      • 8.1.13.3 Middle East Second-generation Antipsychotics Market Size
      • 8.1.13.4 Middle East Benzodiazepines Market Size
      • 8.1.13.5 Middle East Others Market Size
    • 8.1.14 Middle East Delirium Volume Market Sales by Treatment 2022 - 2034
      • 8.1.14.1 Middle East Medication Sales Volume
      • 8.1.14.2 Middle East First-generation Antipsychotics Sales Volume
      • 8.1.14.3 Middle East Second-generation Antipsychotics Sales Volume
      • 8.1.14.4 Middle East Benzodiazepines Sales Volume
      • 8.1.14.5 Middle East Others Sales Volume
    • 8.1.15 Middle East Delirium Market Size by Dosage Form 2022 - 2034
      • 8.1.15.1 Middle East Tablets Market Size
      • 8.1.15.2 Middle East Injections Market Size
      • 8.1.15.3 Middle East Others Market Size
    • 8.1.16 Middle East Delirium Volume Market Sales by Dosage Form 2022 - 2034
      • 8.1.16.1 Middle East Tablets Sales Volume
      • 8.1.16.2 Middle East Injections Sales Volume
      • 8.1.16.3 Middle East Others Sales Volume
  • 9.1 Africa Delirium Market Outlook
    • 9.1.1 Africa Delirium Market Size 2022 - 2034
    • 9.1.2 Africa Delirium Volume Market Sales 2022 - 2034
    • 9.1.3 Africa Delirium Market Size By Country 2022 - 2034
    • 9.1.4 Africa Delirium Volume Market Sales By Country 2022 - 2034
    • 9.1.5 Africa Delirium Market Size by Disease Type 2022 - 2034
      • 9.1.5.1 Africa Hyperactive delirium Market Size
      • 9.1.5.2 Africa Hypoactive delirium Market Size
      • 9.1.5.3 Africa Mixed delirium Market Size
    • 9.1.6 Africa Delirium Volume Market Sales by Disease Type 2022 - 2034
      • 9.1.6.1 Africa Hyperactive delirium Sales Volume
      • 9.1.6.2 Africa Hypoactive delirium Sales Volume
      • 9.1.6.3 Africa Mixed delirium Sales Volume
    • 9.1.7 Africa Delirium Market Size by End-Use 2022 - 2034
      • 9.1.7.1 Africa Hospitals Market Size
      • 9.1.7.2 Africa Speciality clinics Market Size
    • 9.1.8 Africa Delirium Volume Market Sales by End-Use 2022 - 2034
      • 9.1.8.1 Africa Hospitals Sales Volume
      • 9.1.8.2 Africa Speciality clinics Sales Volume
    • 9.1.9 Africa Delirium Market Size by Distribution channel 2022 - 2034
      • 9.1.9.1 Africa Offline Market Size
      • 9.1.9.2 Africa Online Market Size
    • 9.1.10 Africa Delirium Volume Market Sales by Distribution channel 2022 - 2034
      • 9.1.10.1 Africa Offline Sales Volume
      • 9.1.10.2 Africa Online Sales Volume
    • 9.1.11 Africa Delirium Market Size by Route of administration 2022 - 2034
      • 9.1.11.1 Africa Oral Market Size
      • 9.1.11.2 Africa Parenteral Market Size
      • 9.1.11.3 Africa Others Market Size
    • 9.1.12 Africa Delirium Volume Market Sales by Route of administration 2022 - 2034
      • 9.1.12.1 Africa Oral Sales Volume
      • 9.1.12.2 Africa Parenteral Sales Volume
      • 9.1.12.3 Africa Others Sales Volume
    • 9.1.13 Africa Delirium Market Size by Treatment 2022 - 2034
      • 9.1.13.1 Africa Medication Market Size
      • 9.1.13.2 Africa First-generation Antipsychotics Market Size
      • 9.1.13.3 Africa Second-generation Antipsychotics Market Size
      • 9.1.13.4 Africa Benzodiazepines Market Size
      • 9.1.13.5 Africa Others Market Size
    • 9.1.14 Africa Delirium Volume Market Sales by Treatment 2022 - 2034
      • 9.1.14.1 Africa Medication Sales Volume
      • 9.1.14.2 Africa First-generation Antipsychotics Sales Volume
      • 9.1.14.3 Africa Second-generation Antipsychotics Sales Volume
      • 9.1.14.4 Africa Benzodiazepines Sales Volume
      • 9.1.14.5 Africa Others Sales Volume
    • 9.1.15 Africa Delirium Market Size by Dosage Form 2022 - 2034
      • 9.1.15.1 Africa Tablets Market Size
      • 9.1.15.2 Africa Injections Market Size
      • 9.1.15.3 Africa Others Market Size
    • 9.1.16 Africa Delirium Volume Market Sales by Dosage Form 2022 - 2034
      • 9.1.16.1 Africa Tablets Sales Volume
      • 9.1.16.2 Africa Injections Sales Volume
      • 9.1.16.3 Africa Others Sales Volume
  • 10.1 Top Competitors Analysis

    • (Subject to Data Availability (Private Players))

      10.1.1 Global Delirium Market Revenue and Share by Key Players
    • 10.1.2 Global Delirium Market Volume and Share by Key Players
    • 10.1.3 Top Players Ranking 2024
    • 10.1.4 New Product Launch Analysis
    • 10.1.5 Industry Mergers and Acquisition Analysis
  • 10.2 Company Profile (Data Subject to Availability) Sample Format

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.1 Dr Franz Kohler Chemie GmbH
      • 10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.1.2 Business Overview
      • 10.2.1.3 Financials (Subject to data availability)
      • 10.2.1.4 R&D Investment (Subject to data availability)
      • 10.2.1.5 Product Types Specification
      • 10.2.1.6 Business Strategy
      • 10.2.1.7 Recent Developments
      • 10.2.1.8 Management Change
      • 10.2.1.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.2 Gala BioPharma Ltd.
      • 10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.2.2 Business Overview
      • 10.2.2.3 Financials (Subject to data availability)
      • 10.2.2.4 R&D Investment (Subject to data availability)
      • 10.2.2.5 Product Types Specification
      • 10.2.2.6 Business Strategy
      • 10.2.2.7 Recent Developments
      • 10.2.2.8 Management Change
      • 10.2.2.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.3 Teva pharmaceuticals
      • 10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.3.2 Business Overview
      • 10.2.3.3 Financials (Subject to data availability)
      • 10.2.3.4 R&D Investment (Subject to data availability)
      • 10.2.3.5 Product Types Specification
      • 10.2.3.6 Business Strategy
      • 10.2.3.7 Recent Developments
      • 10.2.3.8 Management Change
      • 10.2.3.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.4 Mylan N.V.
      • 10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.4.2 Business Overview
      • 10.2.4.3 Financials (Subject to data availability)
      • 10.2.4.4 R&D Investment (Subject to data availability)
      • 10.2.4.5 Product Types Specification
      • 10.2.4.6 Business Strategy
      • 10.2.4.7 Recent Developments
      • 10.2.4.8 Management Change
      • 10.2.4.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.5 Pfizer Inc.
      • 10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.5.2 Business Overview
      • 10.2.5.3 Financials (Subject to data availability)
      • 10.2.5.4 R&D Investment (Subject to data availability)
      • 10.2.5.5 Product Types Specification
      • 10.2.5.6 Business Strategy
      • 10.2.5.7 Recent Developments
      • 10.2.5.8 Management Change
      • 10.2.5.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.6 Regenstrief Institute Inc
      • 10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.6.2 Business Overview
      • 10.2.6.3 Financials (Subject to data availability)
      • 10.2.6.4 R&D Investment (Subject to data availability)
      • 10.2.6.5 Product Types Specification
      • 10.2.6.6 Business Strategy
      • 10.2.6.7 Recent Developments
      • 10.2.6.8 Management Change
      • 10.2.6.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.7 Novartis AG
      • 10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.7.2 Business Overview
      • 10.2.7.3 Financials (Subject to data availability)
      • 10.2.7.4 R&D Investment (Subject to data availability)
      • 10.2.7.5 Product Types Specification
      • 10.2.7.6 Business Strategy
      • 10.2.7.7 Recent Developments
      • 10.2.7.8 Management Change
      • 10.2.7.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.8 Otsuka Pharmaceutical Co. Ltd.
      • 10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.8.2 Business Overview
      • 10.2.8.3 Financials (Subject to data availability)
      • 10.2.8.4 R&D Investment (Subject to data availability)
      • 10.2.8.5 Product Types Specification
      • 10.2.8.6 Business Strategy
      • 10.2.8.7 Recent Developments
      • 10.2.8.8 Management Change
      • 10.2.8.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.9 Bristol-Myers Squibb
      • 10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.9.2 Business Overview
      • 10.2.9.3 Financials (Subject to data availability)
      • 10.2.9.4 R&D Investment (Subject to data availability)
      • 10.2.9.5 Product Types Specification
      • 10.2.9.6 Business Strategy
      • 10.2.9.7 Recent Developments
      • 10.2.9.8 Management Change
      • 10.2.9.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.10 Fraser Health
      • 10.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.10.2 Business Overview
      • 10.2.10.3 Financials (Subject to data availability)
      • 10.2.10.4 R&D Investment (Subject to data availability)
      • 10.2.10.5 Product Types Specification
      • 10.2.10.6 Business Strategy
      • 10.2.10.7 Recent Developments
      • 10.2.10.8 Management Change
      • 10.2.10.9 S.W.O.T Analysis

    • Data Subject to Availability as we consider Top competitors and their market share will be delivered.

      10.2.11 Zydus Cadila
      • 10.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
      • 10.2.11.2 Business Overview
      • 10.2.11.3 Financials (Subject to data availability)
      • 10.2.11.4 R&D Investment (Subject to data availability)
      • 10.2.11.5 Product Types Specification
      • 10.2.11.6 Business Strategy
      • 10.2.11.7 Recent Developments
      • 10.2.11.8 Management Change
      • 10.2.11.9 S.W.O.T Analysis
  • 11.1 Market Drivers
  • 11.2 Market Restraints
  • 11.3 Market Trends
  • 11.4 Market Opportunity
  • 11.5 Technological Road Map (Subject to Data Availability)
  • 11.6 Product Life Cycle (Subject to Data Availability)
  • 11.7 Customer and Buyer Behavior Analysis
    • 11.7.1 Consumer Demographics and Target Audience Assessment
    • 11.7.2 Consumer Purchase Behavior and Demand Assessment
    • 11.7.3 Consumer Pricing Dynamics and Affordability Assessment
    • 11.7.4 Digital Consumer Engagement and Online Adoption Analysis
    • 11.7.5 Future Consumption Trends and Demand Evolution Analysis
    • 11.7.6 Enterprise Procurement & Purchasing Behavior Analysis
    • 11.7.7 Buyer Decision-Making & Purchase Influence Assessment
    • 11.7.8 Customer Expectations & Service Experience Evaluation
    • 11.7.9 Vendor Selection & Supplier Preference Analysis
    • 11.7.10 Customer Retention & Loyalty Strategy Assessment
    • 11.7.11 Pricing Sensitivity & Value Perception Analysis
    • 11.7.12 Customer Segmentation & Demand Pattern Analysis
    • 11.7.13 Relationship Management & Strategic Partnership Trends
  • 11.8 Market Attractiveness Analysis
  • 11.9 PESTEL Analysis
    • 11.9.1 Political Factors
    • 11.9.2 Economic Factors
    • 11.9.3 Social Factors
    • 11.9.4 Technological Factors
    • 11.9.5 Legal Factors
    • 11.9.6 Environmental Factors
  • 11.10 Industrial Chain Analysis (Subject to Data Availability)
    • 11.10.1 Industry Chain Analysis
    • 11.10.2 Manufacturing Cost Analysis
    • 11.10.3 Supply Side Analysis
      • 11.10.3.1 Raw Material Analysis
      • 11.10.3.2 Raw Material Procurement Analysis
      • 11.10.3.3 Raw Material Price Trend Analysis
  • 11.11 Porter’s Five Forces Analysis
    • 11.11.1 Bargaining Power of Suppliers
    • 11.11.2 Bargaining Power of Buyers
    • 11.11.3 Threat of New Entrants
    • 11.11.4 Threat of Substitutes
    • 11.11.5 Degree of Competition
  • 11.12 Patent Analysis (Subject to Data Availability)
  • 11.13 ESG Analysis
  • 12.1 Hyperactive delirium
    • 12.1.1 Global Delirium Revenue Market Size and Share by Hyperactive delirium 2022 - 2034
    • 12.1.2 Global Delirium Volume Market Sales by Hyperactive delirium 2022 - 2034
  • 12.2 Hypoactive delirium
    • 12.2.1 Global Delirium Revenue Market Size and Share by Hypoactive delirium 2022 - 2034
    • 12.2.2 Global Delirium Volume Market Sales by Hypoactive delirium 2022 - 2034
  • 12.3 Mixed delirium
    • 12.3.1 Global Delirium Revenue Market Size and Share by Mixed delirium 2022 - 2034
    • 12.3.2 Global Delirium Volume Market Sales by Mixed delirium 2022 - 2034
  • 13.1 Hospitals
    • 13.1.1 Global Delirium Revenue Market Size and Share by Hospitals 2022 - 2034
    • 13.1.2 Global Delirium Volume Market Sales by Hospitals 2022 - 2034
  • 13.2 Speciality clinics
    • 13.2.1 Global Delirium Revenue Market Size and Share by Speciality clinics 2022 - 2034
    • 13.2.2 Global Delirium Volume Market Sales by Speciality clinics 2022 - 2034
  • 14.1 Offline
    • 14.1.1 Global Delirium Revenue Market Size and Share by Offline 2022 - 2034
    • 14.1.2 Global Delirium Volume Market Sales by Offline 2022 - 2034
  • 14.2 Online
    • 14.2.1 Global Delirium Revenue Market Size and Share by Online 2022 - 2034
    • 14.2.2 Global Delirium Volume Market Sales by Online 2022 - 2034
  • 15.1 Oral
    • 15.1.1 Global Delirium Revenue Market Size and Share by Oral 2022 - 2034
    • 15.1.2 Global Delirium Volume Market Sales by Oral 2022 - 2034
  • 15.2 Parenteral
    • 15.2.1 Global Delirium Revenue Market Size and Share by Parenteral 2022 - 2034
    • 15.2.2 Global Delirium Volume Market Sales by Parenteral 2022 - 2034
  • 15.3 Others
    • 15.3.1 Global Delirium Revenue Market Size and Share by Others 2022 - 2034
    • 15.3.2 Global Delirium Volume Market Sales by Others 2022 - 2034
  • 16.1 Medication
    • 16.1.1 Global Delirium Revenue Market Size and Share by Medication 2022 - 2034
    • 16.1.2 Global Delirium Volume Market Sales by Medication 2022 - 2034
  • 16.2 First-generation Antipsychotics
    • 16.2.1 Global Delirium Revenue Market Size and Share by First-generation Antipsychotics 2022 - 2034
    • 16.2.2 Global Delirium Volume Market Sales by First-generation Antipsychotics 2022 - 2034
  • 16.3 Second-generation Antipsychotics
    • 16.3.1 Global Delirium Revenue Market Size and Share by Second-generation Antipsychotics 2022 - 2034
    • 16.3.2 Global Delirium Volume Market Sales by Second-generation Antipsychotics 2022 - 2034
  • 16.4 Benzodiazepines
    • 16.4.1 Global Delirium Revenue Market Size and Share by Benzodiazepines 2022 - 2034
    • 16.4.2 Global Delirium Volume Market Sales by Benzodiazepines 2022 - 2034
  • 16.5 Others
    • 16.5.1 Global Delirium Revenue Market Size and Share by Others 2022 - 2034
    • 16.5.2 Global Delirium Volume Market Sales by Others 2022 - 2034
  • 17.1 Tablets
    • 17.1.1 Global Delirium Revenue Market Size and Share by Tablets 2022 - 2034
    • 17.1.2 Global Delirium Volume Market Sales by Tablets 2022 - 2034
  • 17.2 Injections
    • 17.2.1 Global Delirium Revenue Market Size and Share by Injections 2022 - 2034
    • 17.2.2 Global Delirium Volume Market Sales by Injections 2022 - 2034
  • 17.3 Others
    • 17.3.1 Global Delirium Revenue Market Size and Share by Others 2022 - 2034
    • 17.3.2 Global Delirium Volume Market Sales by Others 2022 - 2034
  • 18.1 Global Delirium Price Trend Analysis
  • 18.2 Global Delirium Price Trend Analysis By Region
  • 18.3 North America Delirium Price Trend Analysis
  • 18.4 Europe Delirium Price Trend Analysis
  • 18.5 Asia Pacific Delirium Price Trend Analysis
  • 18.6 South America Delirium Price Trend Analysis
  • 18.7 Middle East Delirium Price Trend Analysis
  • 18.8 Africa Delirium Price Trend Analysis
  • 18.9 Delirium Price Trend Analysis By Disease Type
    • 18.9.1 Global Delirium Price Trend Analysis By Disease Type
  • 19.1 Global Delirium Market Import Data (2022-2025)
  • 19.2 Global Delirium Market Export Data (2019-2023)
  • 19.3 Global Delirium Market Import Data by Region (2019-2023)
  • 19.4 Global Delirium Market Export Data by Region (2019-2023)
  • 19.5 North America Delirium Market Import Data by Country (2019-2023)
  • 19.6 North America Delirium Market Export Data by Country (2019-2023)
  • 19.7 Europe Delirium Market Import Data by Country (2019-2023)
  • 19.8 Europe Delirium Market Export Data by Country (2019-2023)
  • 19.9 Asia Pacific Delirium Market Import Data by Country (2019-2023)
  • 19.10 Asia Pacific Delirium Market Export Data by Country (2019-2023)
  • 19.11 South America Delirium Market Import Data by Country (2019-2023)
  • 19.12 South America Delirium Market Export Data by Country (2019-2023)
  • 19.13 Middle East and Africa Delirium Market Import Data by Country (2019-2023)
  • 19.14 Middle East and Africa Delirium Market Export Data by Country (2019-2023)
  • 20.1 Global Delirium Market Production Data (2022-2025)
  • 20.2 Global Delirium Market Production by Region (2022-2025)
  • 20.3 North America Delirium Production Analysis (2022-2025)
  • 20.4 Europe Delirium Production Analysis (2022-2025)
  • 20.5 Asia Pacific Delirium Production Analysis (2022-2025)
  • 20.6 South America Delirium Production Analysis (2022-2025)
  • 20.7 Middle East Delirium Production Analysis (2022-2025)
  • 20.8 Africa Delirium Production Analysis (2022-2025)
  • 20.9 Delirium Market Production Analysis By Company
    • 20.9.1 Global Delirium Market Production Analysis By Company
    • 20.9.2 North America Delirium Market Production Analysis By Company
    • 20.9.3 Europe Delirium Market Production Analysis By Company
    • 20.9.4 Asia Pacific Delirium Market Production Analysis By Company
    • 20.9.5 South America Delirium Market Production Analysis By Company
    • 20.9.6 Middle East Delirium Market Production Analysis By Company
    • 20.9.7 Africa Delirium Market Production Analysis By Company
  • 21.1 Company Gap Assessment Analysis
  • 21.2 Product & Service Portfolio Gap Analysis
  • 21.3 Demand-Supply Imbalance Analysis
  • 21.4 Market Opportunity & Unmet Needs Analysis
  • 21.5 Technology Adoption & Digital Transformation Gap Analysis
  • 21.6 Operational Efficiency & Process Gap Analysis
  • 21.7 Infrastructure & Capacity Gap Analysis
  • 21.8 Geographic Coverage & Distribution Gap Analysis
  • 21.9 Investment Opportunity & Funding Gap Analysis
  • 21.10 Pricing Structure & Margin Gap Analysis
  • 21.11 Innovation & R&D Capability Gap Analysis
  • 21.12 Policy, Compliance & Regulatory Gap Analysis
  • 21.13 Customer Experience & Expectation Gap Analysis
  • 21.14 Future Growth Opportunity Gap Analysis
  • 21.15 Market Accessibility & Penetration Gap Analysis
  • 22.1 Strategic Commercialization & Pricing Assessment
  • 23.1 Gross Margin Overview and Industry Profitability Trends
  • 23.2 Regional Gross Margin Performance Analysis
  • 23.3 Supply Chain and Distribution Impact on Gross Margins
  • 23.4 Pricing Strategy and Value-Added Margin Assessment
  • 23.5 Key Factors Influencing Gross Margin Variability
  • 23.6 Future Gross Margin Outlook and Profitability Trends
  • 24.1 Global Delirium Market TAM Analysis
  • 24.2 North America Delirium Market TAM Analysis
  • 24.3 Europe Delirium Market TAM Analysis
  • 24.4 Asia Pacific Delirium Market TAM Analysis
  • 24.5 South America Delirium Market TAM Analysis
  • 24.6 Middle East Delirium Market TAM Analysis
  • 24.7 Africa Delirium Market TAM Analysis
  • 25.1 Key Takeaways

  • Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.

    25.2 Analyst Point of View
  • 25.3 Assumptions and Acronyms
  • 26.1 Primary Data Collection
    • 26.1.1 Steps for Primary Data Collection
      • 26.1.1.1 Identification of KOL
    • 26.1.2 Backward Integration
    • 26.1.3 Forward Integration
    • 26.1.4 How Primary Research Help Us
    • 26.1.5 Modes of Primary Research
  • 26.2 Secondary Research
    • 26.2.1 How Secondary Research Help Us
    • 26.2.2 Sources of Secondary Research
  • 26.3 Data Validation
    • 26.3.1 Data Triangulation
    • 26.3.2 Top Down & Bottom Up Approach
    • 26.3.3 Cross check KOL Responses with Secondary Data
  • 26.4 Data Representation
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.

2021

2025

2033

2021

2025

2033

Qualitative Analysis
Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc. Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.

Cognitive's Full Truth Proprietary Research Methodology Implemented by Supriya Yadav and Team

1 Data Gathering
  • 1.1 Research Design & Problem Structuring
    • 1.1.1 Identification of Research Objectives
    • 1.1.2 Market, Region, and Timeframe Definition
    • 1.1.3 Problem Decomposition & Hypothesis Development
    • 1.1.4 Mapping Data Requirements & Analytical Framework
  • 1.2 Data Architecture & Multi-Source Intelligence
    • 1.2.1 Primary Research
      • 1.2.1.1 Manufacturers, distributors, and traders
      • 1.2.1.2 Procurement managers and industry buyers
      • 1.2.1.3 Technology providers and innovators
      • 1.2.1.4 Regulators and policy authorities
      • 1.2.1.5 Subject-matter experts and consultants
      • 1.2.1.6 End users across both B2B and B2C segments
    • 1.2.2 Secondary Research
      • 1.2.2.1 Public data sources
      • 1.2.2.2 Paid Data Sources
    • 1.2.3 Internal Knowledge Systems
  • 2.1 Market Engineering & Quantitative Modelling
    • 2.1.1 Market Sizing and Forecasting Approach
      • 2.1.1.1 Market Sizing Techniques
      • 2.1.1.2 Forecasting Models
  • 2.2 Economic Modelling Framework
    • 2.2.1 Cost Structure & Value Chain Economics
    • 2.2.2 Demand & Price Elasticity Analysis
    • 2.2.3 Supply–Demand Balance Assessment
    • 2.2.4 Economic Impact Assessment
  • 2.3 Industry Structure, Competition & Technology Analysis
    • 2.3.1 Tools and Approaches Applied
  • 2.4 Validation & Sensitivity Analysis
  • 2.5 Insight Development & Recommendations
  • 2.6 Transparent Documentation

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for our full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants your team direct access to our lead analysts for bespoke strategic consultation.

Latest News about Delirium Market

Latest Articles about Delirium Market

By Sneha Mali Published At: Updated At:
Geriatric Population Growth Drives The Delirium Market

Delirium is a neurological illness that causes abnormalities in a persons mental capacity. It produces mental perplexity as well as emotional upheaval.

Sources from Pharma & Healthcare Industry


Citation of Delirium market Report 2026:

https://www.benzinga.com/pressreleases/23/10/35108384/delirium-market-is-projected-to-grow-at-a-cagr-of-6-10-within-the-forecast-period-of-2023-2030-cogn#:~:text=According%20to%20Cognitive%20Market%20Research,in%20a%20persons%20mental%20capacity.


NEED ASSISTANCE?

WRITE US

CALL US

BOOK APPOINTMENT

WRITE AN EMAIL

info@cognitivemarketresearch.com

sales@cognitivemarketresearch.com

CALL US

USA: (+1) 929-659-6832
Europe and UK: (+44) 73-0721-4177
Asia Pacific: (+852) 24529464
Buy Now